HealthEquity, Inc. (HQY)
USD 83.36
(1.41%)
USD 83.36
(1.41%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 1.2 Billion USD | -5.4% |
| 2023 | 1.19 Billion USD | -4.88% |
| 2022 | 1.25 Billion USD | -5.77% |
| 2021 | 1.33 Billion USD | -13.27% |
| 2020 | 1.53 Billion USD | 4560.07% |
| 2019 | 32.93 Million USD | 43.92% |
| 2018 | 22.88 Million USD | 33.08% |
| 2017 | 17.19 Million USD | 5.25% |
| 2016 | 16.33 Million USD | 11.34% |
| 2015 | 14.67 Million USD | -30.4% |
| 2014 | 21.08 Million USD | 153.85% |
| 2013 | 8.3 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.11 Billion USD | 0.04% |
| 2024 FY | 1.2 Billion USD | 0.69% |
| 2024 Q3 | 1.1 Billion USD | -1.01% |
| 2024 Q4 | 1.2 Billion USD | 8.68% |
| 2024 Q1 | 1.11 Billion USD | -6.44% |
| 2023 FY | 1.19 Billion USD | -4.88% |
| 2023 Q2 | 1.2 Billion USD | -0.06% |
| 2023 Q4 | 1.19 Billion USD | 0.98% |
| 2023 Q3 | 1.18 Billion USD | -2.27% |
| 2023 Q1 | 1.2 Billion USD | -3.56% |
| 2022 Q1 | 1.31 Billion USD | -1.33% |
| 2022 FY | 1.25 Billion USD | -5.77% |
| 2022 Q4 | 1.25 Billion USD | 2.18% |
| 2022 Q3 | 1.22 Billion USD | -4.53% |
| 2022 Q2 | 1.28 Billion USD | -2.1% |
| 2021 Q2 | 1.32 Billion USD | -13.0% |
| 2021 Q1 | 1.52 Billion USD | -0.85% |
| 2021 Q3 | 1.3 Billion USD | -1.66% |
| 2021 FY | 1.33 Billion USD | -13.27% |
| 2021 Q4 | 1.33 Billion USD | 2.25% |
| 2020 FY | 1.53 Billion USD | 4560.07% |
| 2020 Q1 | 67.34 Million USD | 104.45% |
| 2020 Q3 | 1.54 Billion USD | 1796.67% |
| 2020 Q2 | 81.3 Million USD | 20.74% |
| 2020 Q4 | 1.53 Billion USD | -0.47% |
| 2019 Q4 | 32.93 Million USD | 57.62% |
| 2019 Q1 | 21.05 Million USD | -7.99% |
| 2019 FY | 32.93 Million USD | 43.92% |
| 2019 Q2 | 21.98 Million USD | 4.4% |
| 2019 Q3 | 20.89 Million USD | -4.94% |
| 2018 FY | 22.88 Million USD | 33.08% |
| 2018 Q4 | 22.88 Million USD | 5.44% |
| 2018 Q3 | 21.7 Million USD | 44.6% |
| 2018 Q2 | 15.01 Million USD | 25.03% |
| 2018 Q1 | 12 Million USD | -30.19% |
| 2017 Q4 | 17.19 Million USD | 44.75% |
| 2017 Q2 | 11.12 Million USD | 17.05% |
| 2017 FY | 17.19 Million USD | 5.25% |
| 2017 Q3 | 11.88 Million USD | 6.78% |
| 2017 Q1 | 9.5 Million USD | -41.82% |
| 2016 FY | 16.33 Million USD | 11.34% |
| 2016 Q4 | 16.33 Million USD | 19.8% |
| 2016 Q3 | 13.63 Million USD | 16.02% |
| 2016 Q2 | 11.75 Million USD | 9.72% |
| 2016 Q1 | 10.71 Million USD | -26.99% |
| 2015 FY | 14.67 Million USD | -30.4% |
| 2015 Q3 | 12.23 Million USD | -1.28% |
| 2015 Q2 | 12.39 Million USD | -79.93% |
| 2015 Q4 | 14.67 Million USD | 19.95% |
| 2015 Q1 | 61.75 Million USD | 192.94% |
| 2014 Q4 | 21.08 Million USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | 21.08 Million USD | 153.85% |
| 2013 FY | 8.3 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Augmedix, Inc. | 43.39 Million USD | -2668.957% |
| OneMedNet Corporation | 13.32 Million USD | -8918.302% |
| Minerva Surgical, Inc. | 51.71 Million USD | -2223.088% |
| CareCloud, Inc. | 37.79 Million USD | -3078.766% |
| CareCloud, Inc. | 37.79 Million USD | -3078.766% |
| iCoreConnect Inc. | 11.24 Million USD | -10587.085% |
| Progyny, Inc. | 203.19 Million USD | -491.305% |
| Renalytix Plc | 15.82 Million USD | -7491.798% |
| Schrödinger, Inc. | 254.39 Million USD | -372.285% |
| Simulations Plus, Inc. | 14.2 Million USD | -8356.349% |
| SOPHiA GENETICS SA | 54.71 Million USD | -2095.924% |
| Omnicell, Inc. | 1.03 Billion USD | -15.758% |
| BrightSpring Health Services, Inc. Common Stock | 5.17 Billion USD | 76.797% |
| Streamline Health Solutions, Inc. | 22.92 Million USD | -5140.679% |
| Inovalon Holdings, Inc. | 1.26 Billion USD | 4.847% |
| Ontrak, Inc. | 5.57 Million USD | -21451.175% |
| Nutex Health, Inc. | 319.13 Million USD | -276.474% |
| GE HealthCare Technologies Inc. | 25.14 Billion USD | 95.222% |
| Sharecare, Inc. | 125.56 Million USD | -856.857% |
| Aclarion, Inc. | 3.18 Million USD | -37590.247% |
| CareMax, Inc. | 561.85 Million USD | -113.841% |
| Bullfrog AI Holdings, Inc. Common Stock | 184.35 Thousand USD | -651637.456% |
| Forian Inc. | 33.19 Million USD | -3519.306% |
| Bullfrog AI Holdings, Inc. Warrants | 184.35 Thousand USD | -651637.456% |
| HeartBeam, Inc. | 1.19 Million USD | -100526.298% |
| GeneDx Holdings Corp. | 245.65 Million USD | -389.088% |
| SCWorx Corp. | 2.42 Million USD | -49450.266% |
| Definitive Healthcare Corp. | 626.72 Million USD | -91.707% |
| 10x Genomics, Inc. | 224.1 Million USD | -436.135% |
| Zhongchao Inc. | 3.37 Million USD | -35462.753% |
| Accolade, Inc. | 342.68 Million USD | -250.606% |
| MSP Recovery, Inc. | 1.74 Billion USD | 30.984% |
| R1 RCM Inc. | 2.2 Billion USD | 45.605% |
| Spok Holdings, Inc. | 63.91 Million USD | -1779.865% |
| Privia Health Group, Inc. | 392.51 Million USD | -206.1% |
| EUDA Health Holdings Limited | 8.79 Million USD | -13564.892% |
| TruBridge, Inc. | 247.8 Million USD | -384.85% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 5.17 Billion USD | 76.797% |
| Sharecare, Inc. | 125.56 Million USD | -856.857% |
| Health Catalyst, Inc. | 334.89 Million USD | -258.763% |
| GoodRx Holdings, Inc. | 826.84 Million USD | -45.309% |
| Premier, Inc. | 1.46 Billion USD | 18.064% |
| HealthStream, Inc. | 159.19 Million USD | -654.745% |
| Certara, Inc. | 516.29 Million USD | -132.709% |
| GeneDx Holdings Corp. | 245.65 Million USD | -389.088% |
| Ontrak, Inc. | 5.57 Million USD | -21451.175% |
| SHL Telemedicine Ltd. | 36.58 Million USD | -3183.784% |
| CareCloud, Inc. | 37.79 Million USD | -3078.766% |
| EUDA Health Holdings Limited | 8.79 Million USD | -13564.892% |
| HeartBeam, Inc. | 1.19 Million USD | -100526.298% |
| Mangoceuticals, Inc. | 276.03 Thousand USD | -435156.612% |
| CareMax, Inc. | 561.85 Million USD | -113.841% |
| Healthcare Triangle, Inc. | 9.51 Million USD | -12532.51% |
| National Research Corporation | 73.48 Million USD | -1535.064% |
| Aclarion, Inc. | 3.18 Million USD | -37590.247% |
| OptimizeRx Corporation | 56.82 Million USD | -2014.507% |